.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Harvard Business School
UBS
Cipla
Covington
Novartis
Cerilliant
Cantor Fitzgerald
Boehringer Ingelheim
US Army

Generated: July 26, 2017

DrugPatentWatch Database Preview

LOMAIRA Drug Profile

« Back to Dashboard

What is the patent landscape for Lomaira, and when can generic versions of Lomaira launch?

Lomaira is a drug marketed by Avanthi Inc and is included in one NDA.

The generic ingredient in LOMAIRA is phentermine hydrochloride. There are seventeen drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the phentermine hydrochloride profile page.

Summary for Tradename: LOMAIRA

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list25
Patent Applications: see list648
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LOMAIRA at DailyMed

Pharmacology for Tradename: LOMAIRA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Avanthi Inc
LOMAIRA
phentermine hydrochloride
TABLET;ORAL203495-001Sep 12, 2016RXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Express Scripts
Deloitte
Cerilliant
Julphar
US Department of Justice
Moodys
Chinese Patent Office
Johnson and Johnson
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot